17 Jan Profacgen
- United States
- January 18, 2025
Company Information
With the vast base of isolation techniques and characterization technologies in our GLP / GMP compliant protein analysis laboratories, underpinned by over 20 years of experience in supporting biologic drug development and bioprocessing, we offer a full spectrum of ready-to-use analytical methods for the detection and quantification of genotoxic impurities.
Sorry, the comment form is closed at this time.